Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,426 | -19,508 | -13,388 | -5,682 | -29,450 |
| Depreciation Amortization | 1,550 | 1,183 | 824 | 420 | 1,770 |
| Accounts receivable | -24 | 16 | 18 | 63 | N/A |
| Other Working Capital | 4,148 | 287 | 1,272 | -1,448 | -2,350 |
| Other Operating Activity | 1,338 | 688 | 353 | 160 | 2,400 |
| Operating Cash Flow | $-22,414 | $-17,334 | $-10,922 | $-6,486 | $-27,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,179 | -1,419 | -877 | -468 | -610 |
| Purchase Of Investment | -10,034 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -103 | -74 | -48 | -35 | N/A |
| Other Investing Activity | 167 | 90 | -49 | -35 | -380 |
| Investing Cash Flow | $-12,046 | $-1,329 | $-926 | $-504 | $-990 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,810 | 985 | 1,008 | N/A | N/A |
| Debt Issued | 23,900 | 12,026 | 12,197 | N/A | N/A |
| Debt Repayment | -11,986 | -112 | -57 | -58 | N/A |
| Common Stock Issued | 18,012 | 16 | N/A | N/A | N/A |
| Other Financing Activity | -2,951 | -3,837 | -3,414 | -410 | 150 |
| Financing Cash Flow | $29,785 | $9,078 | $9,734 | $-469 | $150 |
| Exchange Rate Effect | -37 | -25 | 11 | -53 | -90 |
| Beginning Cash Position | 31,092 | 31,245 | 31,978 | 32,549 | 60,680 |
| End Cash Position | 26,380 | 21,635 | 29,875 | 25,038 | 32,100 |
| Net Cash Flow | $-4,712 | $-9,610 | $-2,102 | $-7,511 | $-28,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,414 | -17,334 | -10,922 | -6,486 | -27,630 |
| Capital Expenditure | -2,179 | -1,419 | -877 | -468 | N/A |
| Free Cash Flow | -24,593 | -18,753 | -11,798 | -6,955 | -27,630 |